GE HealthCare Technologies Inc. (GEHC)

Market Cap	31.76B
Revenue (ttm)	19.80B
Net Income (ttm)	2.18B
Shares Out	457.88M
EPS (ttm)	4.76
PE Ratio	14.57
Forward PE	17.48
Dividend	$0.14 (0.20%)
Ex-Dividend Date	Apr 25, 2025

Volume	5,927,329
Open	70.14
Previous Close	70.53
Day's Range	69.21 - 70.56
52-Week Range	57.65 - 94.80
Beta	1.38
Analysts	Strong Buy
Price Target	90.00 (+29.74%)
Earnings Date	Apr 30, 2025

About GEHC

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1892
• Employees: 53,000
• Stock Exchange: NASDAQ
• Ticker Symbol: GEHC
• Website: https://www.gehealthcare.com

Financial Performance

In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.

Analyst Forecast

According to 9 analysts, the average rating for GEHC stock is "Strong Buy." The 12-month stock price forecast is $90.0, which is an increase of 29.74% from the latest price.

Price Target

$90.0

(29.74% upside)

Analyst Consensus: Strong Buy